ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

A1LN34 Alnylam Pharmaceuticals Inc

65,56
15,87 (31,94%)
Dernière mise à jour : 16:15:51
Retardé de 15 minutes
Quarter End Juin 2022Sept 2022Déc 2022Mar 2023Juin 2023Sept 2023Déc 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 224,82M264,31M335,04M319,29M318,75M750,53M439,72M494,33M
Revenu d'exploitation -191,69M-258,04M-188,61M-149,81M-229,83M213,87M-116,4M-43,44M
Revenu avant impôt -274,67M-405,94M-207,02M-172,36M-274,21M150,74M-137,69M-63,59M
Revenu net -277,4M-405,92M-207,49M-174,1M-276,02M147,75M-137,87M-65,94M
Dividendes privilégiés 00000000
Résultat de base par action 00000000
EBIT -231,05M-288,27M-73,95M-153,32M-273,99M156,21M-136,76M-49,47M
EBITDA -181,59M-247,44M-174,3M-135,74M-216,65M227,2M-102,92M-29,92M
Fin d'année 31 Décembre 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 47,16M89,91M74,91M219,75M492,85M844,29M1,04B1,83B
Revenu d'exploitation -424,59M-500,09M-814,67M-939,43M-828,44M-708,65M-785,07M-282,18M
Revenu avant impôt -410,11M-490,87M-760,67M-885,25M-855,6M-852,14M-1,13B-433,52M
Revenu net -410,11M-490,87M-761,5M-886,12M-858,28M-852,82M-1,13B-440,24M
Dividendes privilégiés 00000000
Résultat de base par action -4.772-4.925-7.526-7.898-7.372-7.096-9.128-3.508
EBIT -418,42M-503,11M-789,94M-918,7M-782,91M-727,96M-791,28M-407,86M
EBITDA -414,99M-488,19M-801,87M-922,83M-798,24M-661,09M-740,6M-228,12M

Dernières Valeurs Consultées

Delayed Upgrade Clock